Breast cancer metastasis: markers and models
The DOI matches its Crossref record; 115 of the 115 references it cites were found in a registry or an index.
Abstract
Breast cancer starts as a local disease, but it can metastasize to the lymph nodes and distant organs. At primary diagnosis, prognostic markers are used to assess whether the transition to systemic disease is likely to have occurred. The prevailing model of metastasis reflects this view--it suggests that metastatic capacity is a late, acquired event in tumorigenesis. Others have proposed the idea that breast cancer is intrinsically a systemic disease. New molecular technologies, such as DNA microarrays, support the idea that metastatic capacity might be an inherent feature of breast tumours. These data have important implications for prognosis prediction and our understanding of metastasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Immune cells were shown to both enhance and inhibit malignant cells proliferation, migration, and metastasis [125-128].”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [125]
In the citing paper
“Chemical gradients play an important role in tumor cell invasion of metastatic cancer [195,196] as it significantly directs the migration and differentiation of tumor cells.”
From Microfluidic modelling of the tumor microenvironment for anti-cancer drug development (2019) · cites this paper as [196]
In the citing paper
“Metastasis is the leading cause of death from breast cancer1, 37-39.”
From Liposomal Formulation of HIF-1α Inhibitor Echinomycin Eliminates Established Metastases of Triple-negative Breast Cancer (2020) · cites this paper as [1]
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Cluster analysis and display of genome-wide expression patterns
Eisen, M. B., Spellman, P. T., Brown, P. O., & Botstein, D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14863 · Cited by 16,184
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760 · cited 1×
“ERBB2 is overexpressed due to gene amplification in 15–30% of human breast cancer”
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Slamon, D. J., Leyland-Jones, B., Shak, S., Fuchs, H., Paton, V., Bajamonde, A., Fleming, T., Eiermann, W., Wolter, J., Pegram, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200103153441101 · Cited by 11,500
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Research works printed but not linked: 2
- Fidler, I. J. Metastasis: quantitative analysis of distribution and fate of tumour embolilabeled with 125 I-5-iodo-2′-deoxyuridine. J. Natl Cancer Inst. 45, 773–782 (1970).
- Leighton, J. Inherent malignancy of cancer cells possibly limited by genetically differing cells in the same tumour. Acta Cytol. 9, 138–140 (1965).
Cited by
Items 501–600 of 1,003
Bendinelli, P., Matteucci, E., Maroni, P., & Desiderio, M. A. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0548 · Cited by 64
Apoptosis Inhibitor ARC Promotes Breast Tumorigenesis, Metastasis, and Chemoresistance
Medina-Ramirez, C. M., Goswami, S., Смирнова, Т. А., Bamira, D. G., Benson, B., Ferrick, N. J., Segall, J. E., Pollard, J. W., & Kitsis, R. N. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2192 · Cited by 60
“Breast cancer is the second most common cause of cancer deaths in women with mortality attributable to the metastatic spread to vital organs such as lung, liver, and bone (1).”
Liu, C., Li, Y., Xing, Y., Cao, B., Yang, F., Yang, T., Ai, Z., Wei, Y., & Jiang, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.712976 · Cited by 66
“This accounts for over 90% of lethality in cancer patients (2).”
BackgroundIdentification of five hub genes as monitoring biomarkers for breast cancer metastasis in silico
Cai, Y., Mei, J., Xiao, Z., Xu, B., Jiang, X., Zhang, Y., & Zhu, Y. (2019) · Hereditas · doi:10.1186/s41065-019-0096-6 · Cited by 67
“Although advanced therapies have achieved promising performance in controlling breast cancer with no metastasis, there are rarely available strategies to control advanced breast cancer, and even precise methods that can prevent the recurrence and metastasis of breast cancer are quite scarce [23, 24].”
BackgroundThe emerging role of radionuclide molecular imaging of HER2 expression in breast cancer
Максимилианович, Т. В., Orlova, A., & Sørensen, J. C. H. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2020.10.005 · Cited by 60
Lee, J. (2019) · Nutrition and Cancer · doi:10.1080/01635581.2019.1577979 · Cited by 60
Cancer-Associated Fibroblasts in Breast Cancer Treatment Response and Metastasis
Fernández‐Nogueira, P., Fuster, G., Gutiérrez-Uzquiza, Á., Gascón, P., Carbó, N., & Bragado, P. (2021) · Cancers · doi:10.3390/cancers13133146 · Cited by 64
Zhu, Y., Shen, T., Liu, J., Zheng, J., Zhang, Y., Xu, R., Sun, C., Du, J., Chen, Y., & Gu, L. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.01.015 · Cited by 59
The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas
Klopfleisch, R., Lenze, D., Hummel, M., & Gruber, A. D. (2010) · The Veterinary Journal · doi:10.1016/j.tvjl.2010.10.018 · Cited by 59
Reagan, M. R., Seib, F. P., McMillin, D. W., Sage, E. K., Mitsiades, C. S., Janes, S. M., Ghobrial, I. M., & Kaplan, D. L. (2012) · Journal of Breast Cancer · doi:10.4048/jbc.2012.15.3.273 · Cited by 58
“More-over, many life-threatening tumors occur at multiple, distant locations that require systemic treatment and may occur years after primary tumor removal; in fact, 90% of patients die due to metastasis, based on work by Weigelt et al. [21].”
BackgroundInterfacing Inorganic Nanowire Arrays and Living Cells for Cellular Function Analysis
Kwak, M., Han, L. G., Chen, J. J. F., & Fan, R. (2015) · Small · doi:10.1002/smll.201501236 · Cited by 65
Volatile Anesthetics Modulate Gene Expression in Breast and Brain Tumor Cells
Huitink, J. M., Heimerikxs, M., Nieuwland, M., Loer, S. A., Brugman, W., Velds, A., Sie, D., & Kerkhoven, R. M. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181fa3533 · Cited by 65
Chen, G., Wang, Y., Wu, P., Zhou, Y., Yu, F., Zhu, C., Li, Z., Hang, Y., Wang, K., Li, J., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b01482 · Cited by 60
Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer
Salimifard, S., Masjedi, A., Hojjat‐Farsangi, M., Ghalamfarsa, G., Irandoust, M., Azizi, G., Mohammadi, H., Keramati, M. R., & Jadidi‐Niaragh, F. (2020) · Pathology - Research and Practice · doi:10.1016/j.prp.2020.152915 · Cited by 60
Cava, C., & Castiglioni, I. (2020) · Applied Sciences · doi:10.3390/app10196981 · Cited by 60
Yasothamani, V., Karthikeyan, L., Shyamsivappan, S., Haldorai, Y., Dayakar, S., & Vivek, R. (2021) · Biomacromolecules · doi:10.1021/acs.biomac.1c00244 · Cited by 58
Amine, A., Rivera, S., Opolon, P., Dekkal, M., Biard, D. S. F., Bouamar, H., Louache, F., McKay, M. J., Bourhis, J., Deutsch, É., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005018 · Cited by 61
“In the classical model of metastasis [35], a small subpopulation”
BackgroundDavis, F. M., Kenny, P. A., Soo, E., van Denderen, B. J. W., Thompson, E. W., Cabot, P. J., Parat, M., Roberts‐Thomson, S. J., & Monteith, G. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023464 · Cited by 62
Vazquez, A. I., Veturi, Y., Behring, M. P., Shrestha, S., Kirst, M., Resende, M. F. R., & Campos, G. D. L. (2016) · Genetics · doi:10.1534/genetics.115.185181 · Cited by 59
Rovito, D., Gionfriddo, G., Barone, I., Giordano, C., Grande, F., Amicis, F. D., Lanzino, M., Catalano, S., Andò, S., & Bonofiglio, D. (2016) · Oncotarget · doi:10.18632/oncotarget.11371 · Cited by 60
l-arginine alters the effect of 5-fluorouracil on breast cancer cells in favor of apoptosis
Jahani, M., Azadbakht, M., Norooznezhad, F., & Mansouri, K. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.01.047 · Cited by 65
Chemotherapy Induces Breast Cancer Stemness in Association with Dysregulated Monocytosis
Liu, L., Yang, L., Yan, W., Zhai, J., Pizzo, D. P., Chu, P. G., Chin, A. R., Shen, M., Dong, C., Ruan, X., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2545 · Cited by 63
Li, Q., Yang, J., Chen, C., Lin, X., Zhou, M., Zhou, Z., & Huang, Y. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.06.010 · Cited by 62
Recent advances in fluorescent probes for extracellular pH detection and imaging
Chen, Y. (2020) · Analytical Biochemistry · doi:10.1016/j.ab.2020.113900 · Cited by 60
Wu, P., Zhu, Y., Liu, S., & Xiong, H. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c01066 · Cited by 59
Luo, M., Fu, A., Wu, R., Wei, N., Song, K., Lim, S., & Luo, K. Q. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.65555 · Cited by 58
The prognostic significance of RUNX2 and miR-10a/10b and their inter-relationship in breast cancer
Chang, C., Fan, T.-C., Yu, J., Liao, G., Lin, Y.-C., Shih, A. C.-C., Li, W., & Yu, A. L.-T. (2014) · Journal of Translational Medicine · doi:10.1186/s12967-014-0257-3 · Cited by 58
“Approximately 10 ~ 15% breast cancer patients have an aggressive disease and develop distant metastases [1] to bone, lung, liver and brain [2].”
BackgroundKim, E. J., Shin, M., Park, H., Hong, J. E., Shin, H., Kim, J., Kwon, D. Y., & Park, J. H. Y. (2009) · Journal of Nutrition · doi:10.3945/jn.109.111864 · Cited by 58
Kijanka, M. M., van Brussel, A. S. A., van der Wall, E., Mali, W. P. T. M., van Diest, P. J., Henegouwen, P. M. P. V. B. E., & Oliveira, S. (2016) · EJNMMI Research · doi:10.1186/s13550-016-0166-y · Cited by 57
Smart Radiation Therapy Biomaterials
Ngwa, W. F., Boateng, F., Kumar, R., Irvine, D. J., Formenti, S. C., Ngoma, T. A., Herskind, C., Veldwijk, M. R., Hildenbrand, G. L., Hausmann, M., et al. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2016.10.034 · Cited by 57
Gupta, B., Ramasamy, T., Poudel, B. K., Pathak, S., Regmi, S., Choi, J. Y., Son, Y., Thapa, R. K., Jeong, J., Kim, J. R., et al. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.6b09163 · Cited by 57
Yu, F., Wu, H., Tang, Y., Xu, Y. F., Qian, X. H., & Zhu, W. P. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.11.025 · Cited by 59
Yang, Y., Zhu, G., Dong, B., Piao, J., Chen, L., & Lin, Z. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.03.054 · Cited by 59
Mun, S. G., Choi, H. W., Lee, J. M., Lim, J. H., Ha, J. H., Kang, M., Kim, E.-J., Kang, L., & Chung, B. G. (2020) · Nano Convergence · doi:10.1186/s40580-020-0220-3 · Cited by 59
Hepatic lipids promote liver metastasis
Li, Y., Su, X., Rohatgi, N., Zhang, Y., Brestoff, J. R., Shoghi, K. I., Xu, Y., Semenkovich, C. F., Harris, C. A., Peterson, L. L., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.136215 · Cited by 57
A Requirement for Dimerization of HP1Hsα in Suppression of Breast Cancer Invasion
Norwood, L. E., Moss, T. J. M., Margaryan, N. V., Cook, S. L., Wright, L., Seftor, E. A., Hendrix, M. J. C., Kirschmann, D. A., & Wallrath, L. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512454200 · Cited by 64
Ravindranathan, S., Nguyen, K. G., Kurtz, S. L., Frazier, H. N., Smith, S. G., Koppolu, B., Rajaram, N., & Zaharoff, D. A. (2018) · Breast Cancer Research · doi:10.1186/s13058-018-1054-3 · Cited by 56
Abdellatef, A. A., Fathy, M., Mohammed, A. E.-S. I., Bakr, M. S. A., Ahmed, A. H., Abbass, H. S., El‐Desoky, A. H., Morita, H., Nikaido, T., & Hayakawa, Y. (2021) · Journal of Natural Medicines · doi:10.1007/s11418-021-01526-w · Cited by 61
Chen, L., Shen, J., Kang, Z., Zhang, Z., Zheng, Z., Zhang, L., Xiao, Z., Zhang, Q., Fang, H., Zhou, J., et al. (2024) · Chem · doi:10.1016/j.chempr.2024.01.030 · Cited by 57
Lainé, A.-L., Adriaenssens, É., Vessières, A., Jaouen, G., Corbet, C., Desruelles, E., Pigeon, P., Toillon, R., & Passirani, C. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.05.065 · Cited by 57
“Metastatic breast cancer is the most advanced stage and the main cause of mortality for breast cancer patients [44].”
BackgroundTherapeutic implications of cancer initiating cells
Scopelliti, A., Cammareri, P., Catalano, V., Saladino, V., Todaro, M., & Stassi, G. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903066687 · Cited by 67
Shi, X., Chen, G., Liu, X., Qiu, Y., Yang, S., Zhang, Y., Fang, X., Zhang, C., & Liu, X. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1997 · Cited by 58
“Tumor cell dissemination, epithelial-mesenchymal transition (EMT), invasion and cell migration are the initial and critical steps of the metastatic cascade (3,4).”
Paholak, H. J., Stevers, N. O., Chen, H., Burnett, J., He, M., Körkaya, H., McDermott, S., Deol, Y. S., Clouthier, S. G., Luther, T. K., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.06.045 · Cited by 60
“With metastasis being the primary cause of death in breast cancer patients [15, 16], to be most effective future therapies must perform two essenti al roles: act locally against all populations of cancer cells to prevent future metastasis, and act systemically against all populations of cancer cells in existing metast…”
BackgroundHain, B. A., Xu, H., Hagerty, J., Mutua, D., & Waning, D. L. (2019) · JCSM Rapid Communications · doi:10.1002/j.2617-1619.2019.tb00011.x · Cited by 56
Wei, R., Jiang, G., Lv, M., Tan, S., Wang, X., Zhou, Y., Cheng, T., Gao, X., Chen, X., Wang, W., et al. (2019) · Theranostics · doi:10.7150/thno.35346 · Cited by 55
Avagliano, A., Fiume, G., Ruocco, M. R., Martucci, N., Vecchio, E., Insabato, L., Russo, D., Accurso, A., Masone, S., Montagnani, S., et al. (2020) · Cancers · doi:10.3390/cancers12061697 · Cited by 66
Extracellular Hsp90α Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer
Hou, Q., Chen, S., An, Q., Li, X., Fu, Y., & Luo, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147747 · Cited by 58
Lee, W. S., Kim, M. J., Yun, S. H., Chun, H.-K., Lee, W. Y., Kim, S.-J., Choi, S., Heo, J.-S., Joh, J., & Kim, Y. I. (2007) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-007-0231-0 · Cited by 56
Ghosh, A., Sarkar, S., Banerjee, S., Behbod, F., Tawfik, O. W., McGregor, D. H., Graff, S. L., & Banerjee, S. K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0198143 · Cited by 58
Cancer stem cells in osteosarcoma: Recent progress and perspective
Liu, B., Ma, W., Jha, R. K., & Gurung, K. (2011) · Acta Oncologica · doi:10.3109/0284186x.2011.584553 · Cited by 55
Blocking the Adhesion Cascade at the Premetastatic Niche for Prevention of Breast Cancer Metastasis
Kang, S. A., Hasan, N., Mann, A. P., Zheng, W., Zhao, L., Morris, L. M., Zhu, W., Zhao, Y. D., Suh, K. S., Dooley, W. C., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.45 · Cited by 56
The Effectiveness of Raloxifene-Loaded Liposomes and Cochleates in Breast Cancer Therapy
Ağardan, N. B. M., Değim, Z., Yılmaz, Ş., Altıntaş, L., & Topal, T. (2015) · AAPS PharmSciTech · doi:10.1208/s12249-015-0429-3 · Cited by 61
Göbel, A., Thiele, S., Browne, A. J., Rauner, M., Zinna, V. M., Hofbauer, L. C., & Rachner, T. D. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.03.004 · Cited by 55
Pickles, M. D., Lowry, M., & Gibbs, P. (2015) · Investigative Radiology · doi:10.1097/rli.0000000000000222 · Cited by 58
Hamdoun, S., & Efferth, T. (2017) · Oncotarget · doi:10.18632/oncotarget.16626 · Cited by 57
Li, R., Chen, F., Liu, H. Q., Wang, Z. X., Zhang, Z.-N., Wang, Y., Cui, H., Liu, W., Zhao, X., Sun, Z., et al. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b04683 · Cited by 55
Duan, Z., Cai, H., Zhang, H., Chen, K., Li, N., Xu, Z., Gong, Q., & Luo, K. (2018) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.8b12232 · Cited by 56
Iron Oxide Nanoparticles for Breast Cancer Theranostics
Shakil, M. S., Hasan, M. A., & Sarker, S. R. (2018) · Current Drug Metabolism · doi:10.2174/1389200220666181122105043 · Cited by 56
A Multidisciplinary Approach to the Management of Breast Cancer, Part 1: Prevention and Diagnosis
Pruthi, S., Brandt, K. R., Degnim, A. C., Goetz, M. P., Perez, E. A., Reynolds, C. A., Schomberg, P. J., Dy, G. K., & Ingle, J. N. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.8.999 · Cited by 70
Controlled tumor heterogeneity in a co-culture system by 3D bio-printed tumor-on-chip model
Moghimi, N., Hosseini, S. A., Dalan, A. B., Mohammadrezaei, D., Goldman, A. J., & Kohandel, M. (2023) · Scientific Reports · doi:10.1038/s41598-023-40680-x · Cited by 60
“In many metastases cases, death results from distant metastases to other organs and tissues.(27,28) Angiogenesis modeling is also a critical factor in tumor development and metastasis, allowing investigation of vascular endothelial cells' interactions with cancer cells, including the co-culture of tumor cells with end…”
BackgroundExpression of tenascin-C and its isoforms in the breast
Guttery, D. S., Shaw, J., Lloyd, K., Pringle, J. H., & Walker, R. A. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9249-9 · Cited by 57
Prognostic significance of CXCL12, CXCR4, and CXCR7 in patients with breast cancer.
Wu, W. D., Qian, L., Chen, X., & Ding, B. (2015) · PubMed Central · Cited by 54
Su, J.-C., Mar, A.-C., Wu, S., Tai, W., Chu, P., Wu, C.-Y., Tseng, L., Lee, T., Chen, K., Liu, C., et al. (2016) · Scientific Reports · doi:10.1038/srep28888 · Cited by 55
Prieto‐Vila, M., Usuba, W., Takahashi, R., Shimomura, I., Sasaki, H., Ochiya, T., & Yamamoto, Y. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0122 · Cited by 57
Alkhatib, M. H., Bawadud, R. S., & Gashlan, H. M. (2020) · Scientific Reports · doi:10.1038/s41598-020-75017-5 · Cited by 54
Hong, H., Zhou, T., Fang, S., Jia, M., Xu, Z., Dai, Z., Li, C., Li, S., Li, L., Zhang, T., et al. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3154-9 · Cited by 53
Khan, S. U., Shukla, S., Sinha, S., Lakra, A. D., Bora, H. K., & Meeran, S. M. (2014) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2014.10.028 · Cited by 53
Yu, Y., Du, J., Hu, Z., Liu, J., Tian, Y., Zhu, Y., Wang, L., & Gu, L. (2011) · Journal of Biomedical Research · doi:10.1016/s1674-8301(11)60032-8 · Cited by 53
Fu, M., Maresh, E. L., Helguera, G. F., Kiyohara, M., Yu, Q., Ashki, N., Daniels‐Wells, T. R., Aziz, N., Gordon, L. K., Braun, J. G., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0199 · Cited by 53
“Mol Cancer Ther; 13(4) April 2014 Molecular Cancer Therapeutics OF4”
InfluentialQuantifying collagen fiber orientation in breast cancer using quantitative phase imaging
Majeed, H., Okoro, C., Kajdacsy‐Balla, A., Toussaint, K. C., & Popescu, G. (2017) · Journal of Biomedical Optics · doi:10.1117/1.jbo.22.4.046004 · Cited by 53
Henry, K. E., Ulaner, G. A., & Lewis, J. S. (2017) · PET Clinics · doi:10.1016/j.cpet.2017.02.001 · Cited by 54
Quercetin Inhibits Lef1 and Resensitizes Docetaxel-Resistant Breast Cancer Cells
Prieto‐Vila, M., Shimomura, I., Kogure, A., Usuba, W., Takahashi, R., Ochiya, T., & Yamamoto, Y. (2020) · Molecules · doi:10.3390/molecules25112576 · Cited by 53
Dhakal, H. P., Naume, B., Synnestvedt, M., Borgen, E., Kaaresen, R., Schlichting, E., Wiedswang, G., Bassarova, A. V., Holm, R., Giercksky, K.-E., et al. (2012) · Histopathology · doi:10.1111/j.1365-2559.2012.04223.x · Cited by 52
Chen, C., Cheng, C.-T., Yuan, Y., Zhai, J., Arif, M., Fong, L. W. R., Wu, R., & Ann, D. K. (2015) · Oncotarget · doi:10.18632/oncotarget.3827 · Cited by 52
Okada, F., Kobayashi, M., Tanaka, H., Kobayashi, T., Tazawa, H., Iuchi, Y., Onuma, K., Hosokawa, M., Dinauer, M. C., & Hunt, N. H. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.060073 · Cited by 52
Stübke, K., Wicklein, D., Herich, L., Schumacher, U., & Nehmann, N. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.02.019 · Cited by 52
A FTIR Imaging Characterization of Fibroblasts Stimulated by Various Breast Cancer Cell Lines
Kumar, S., Salammal, S. T., & Goormaghtigh, E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111137 · Cited by 56
Hu, X., Wei, C., Xia, J., Pelivanov, I., O’Donnell, M., & Gao, X. (2012) · Small · doi:10.1002/smll.201202085 · Cited by 52
Shi, W., Paproski, R. J., Moore, R. B., & Zemp, R. J. (2014) · Journal of Biomedical Optics · doi:10.1117/1.jbo.19.5.056014 · Cited by 52
“Metastasis, the spread of cancer cells from the primary tumor to distant sites in the body, is known to cause >90% of cancerassociated deaths.(1) Circulating tumor cells (CTCs) are a marker of cancer metastasis and hence a source of biomarkers for tumor research and diagnosis.”
BackgroundMenezes, S. V., Sahni, S., Kovačević, Ž., & Richardson, D. R. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.r117.776393 · Cited by 54
Breast Carcinoma: From Initial Tumor Cell Detachment to Settlement at Secondary Sites
Melzer, C., von der Ohe, J., & Hass, R. (2017) · BioMed Research International · doi:10.1155/2017/8534371 · Cited by 58
“Thus, different single cancer cell progenies acquire the capability to metastasize to distinct tissues/organs with features of an organspecific homing whereby early dissemination of cancer cells favors metastatic capacity [2, 130, 135].”
BackgroundZhao, C., Xie, P., Wang, H., & Cai, Z. (2018) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2018.05.010 · Cited by 52
Molecular Mechanisms of Breast Cancer Metastasis and Potential Anti-metastatic Compounds
Tungsukruthai, S., Petpiroon, N., & Pithi Chanvorachote, B. (2018) · Anticancer Research · doi:10.21873/anticanres.12502 · Cited by 53
Arzi, L., Farahi, A., Jafarzadeh, N., Riazi, G. H., Sadeghizadeh, M., & Hoshyar, R. (2018) · DNA and Cell Biology · doi:10.1089/dna.2018.4351 · Cited by 58
“B reast cancer is the most prevailing cancer in women worldwide and, owing to high metastatic potency, it is the primary cause of cancer mortality (Weigelt et al. , 2005; Jemal et al. , 2011).”
CircRNA circFOXK2 facilitates oncogenesis in breast cancer via IGF2BP3/miR-370 axis
Zhang, W., Liu, H., Jiang, J., Yang, Y., Wang, W., & Jia, Z. (2021) · Aging · doi:10.18632/aging.203347 · Cited by 53
Ji, P., Yang, Z., Li, H., Wei, M., Yang, G., Xing, H., & Li, Q. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.10.009 · Cited by 56
Wang, L., Fan, Z., Zhang, J., Changyi, Y., Huang, C., Gu, Y., Xu, Z., Tang, Z., Lu, W., Wei, X., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29153 · Cited by 51
Guo, K., Tang, J. P., Jie, L., Al-Aidaroos, A. Q., Hong, C. W., Tan, C. P. B., Park, J. E., Varghese, L., Feng, Z., Zhou, J., et al. (2012) · Oncotarget · doi:10.18632/oncotarget.442 · Cited by 51
“When we employed an experimental metastatic assay [19] in which cultured cancer cells were introduced into the circulation of nude mice by lateral tail vein injection, both B16F0 and B16F10 cells rapidly formed multiple metastatic tumors in mice within 17 days.”
Katz, E., Dubois-Marshall, S., Sims, A. H., Gautier, P. E., Caldwell, H., Meehan, R. R., & Harrison, D. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017083 · Cited by 54
Jia, S., Li, P., Koh, K., & Chen, H. (2015) · Microchimica Acta · doi:10.1007/s00604-015-1700-8 · Cited by 51
MenaINV dysregulates cortactin phosphorylation to promote invadopodium maturation
Weidmann, M. D., Surve, C. R., Eddy, R. J., Chen, X., Gertler, F. B., Sharma, V. P., & Condeelis, J. S. (2016) · Scientific Reports · doi:10.1038/srep36142 · Cited by 51
The T-LAK Cell-originated Protein Kinase Signal Pathway Promotes Colorectal Cancer Metastasis
Zykova, T. A., Zhu, F., Wang, L., Li, H., Bai, R., Lim, D. Y., Yao, K., Bode, A. M., & Dong, Z. (2017) · EBioMedicine · doi:10.1016/j.ebiom.2017.04.003 · Cited by 51
Comparison of breast cancer metastasis models reveals a possible mechanism of tumor aggressiveness
Pillar, N., Polsky, A. L., Weissglas‐Volkov, D., & Shomron, N. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-1094-8 · Cited by 57
Melatonin and non-small cell lung cancer: new insights into signaling pathways
Pourhanifeh, M. H., Sharifi, M., Reiter, R. J., Davoodabadi, A., & Asemi, Z. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0853-7 · Cited by 54
Gong, T., Dong, Z., Fu, Y. S., Gong, T., Deng, L., & Zhang, Z. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb01250h · Cited by 50
Bekkhus, T., Martikainen, T., Olofsson, A., Boger, M. F., Bacovia, D. V., Wärnberg, F., & Ulvmar, M. H. (2021) · Cancers · doi:10.3390/cancers13020211 · Cited by 51
Ren, L., Hong, S.-H., Chen, Q.-R., Briggs, J., Cassavaugh, J., Srinivasan, S., Lizardo, M. M., Mendoza, A., Xia, A. Y., Avadhani, N., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-0210 · Cited by 50
“Several models describing the process of metastatic progression from a primary tumor to distant metastatic sites have been established (32-35).”
In vitro bone metastasis dwelling in a 3D bioengineered niche
Han, W., Botty, R. E., Montaudon, É., Malaquin, L., Deschaseaux, F., Espagnolle, N., Marangoni, E., Cottu, P. H., Zalcman, G., Parrini, M. C., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120624 · Cited by 50
Wang, Z., Yu, Y., Dai, W., Cui, J., Wu, H., Yuan, L., Zhang, H., Wang, X., Wang, J., Zhang, X., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.10.018 · Cited by 51
Khanal, A., Bui, M.-P. N., & Seo, S. S. (2014) · Journal of Breast Cancer · doi:10.4048/jbc.2014.17.1.18 · Cited by 50
Metadata
- Authors
- Weigelt, B., Peterse, J. L., & van't Veer, L. J.
- Affiliations
- The Netherlands Cancer Institute (NL)
- ORCID
- Weigelt, Britta
- Venue
- Nature Reviews Cancer
- Published
- 2005-08-01
- Volume
- 5
- Issue
- 8
- Pages
- 591-602
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2004280628
- Semantic Scholar
- 3bd1490d7b6c8daa59bd35260c6c71e39d3d62fa
- Cited by
- 2,232
- References
- 112
- Citations by year
- 2026: 34 · 2025: 69 · 2024: 90 · 2023: 111 · 2022: 139 · 2021: 154 · 2020: 159 · 2019: 147 · 2018: 140 · 2017: 191 · 2016: 162 · 2015: 152 · 2014: 121 · 2013: 104 · 2012: 88
- FWCI
- 5.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- breast cancer, metastasis, prognostic factors, metastatic potential, lymph node metastasis, distant metastasis, carcinogenesis, DNA microarrays, systemic disease, metastasis model
- MeSH terms
- Breast Neoplasms, Female, Humans, Neoplasm Metastasis, Biomarkers, Tumor, Models, Animal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.